These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 14684360

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Comparison of bisoprolol and carvedilol cardioprotection in a rabbit ischemia and reperfusion model.
    Gao F, Chen J, Lopez BL, Christopher TA, Gu J, Lysko P, Ruffolo RR, Ohlstein EH, Ma XL, Yue TL.
    Eur J Pharmacol; 2000 Oct 06; 406(1):109-16. PubMed ID: 11011041
    [Abstract] [Full Text] [Related]

  • 23. Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger.
    Yue TL, Cheng HY, Lysko PG, McKenna PJ, Feuerstein R, Gu JL, Lysko KA, Davis LL, Feuerstein G.
    J Pharmacol Exp Ther; 1992 Oct 06; 263(1):92-8. PubMed ID: 1357162
    [Abstract] [Full Text] [Related]

  • 24. The antioxidant edaravone attenuates ER-stress-mediated cardiac apoptosis and dysfunction in rats with autoimmune myocarditis.
    Shimazaki H, Watanabe K, Veeraveedu PT, Harima M, Thandavarayan RA, Arozal W, Tachikawa H, Kodama M, Aizawa Y.
    Free Radic Res; 2010 Sep 06; 44(9):1082-90. PubMed ID: 20815771
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Effects of carvedilol on oxidative stress in human endothelial cells and healthy volunteers.
    Fahlbusch SA, Tsikas D, Mehls C, Gutzki FM, Böger RH, Frölich JC, Stichtenoth DO.
    Eur J Clin Pharmacol; 2004 Apr 06; 60(2):83-8. PubMed ID: 15004731
    [Abstract] [Full Text] [Related]

  • 27. Oleanolic acid modulates the immune-inflammatory response in mice with experimental autoimmune myocarditis and protects from cardiac injury. Therapeutic implications for the human disease.
    Martín R, Cordova C, San Román JA, Gutierrez B, Cachofeiro V, Nieto ML.
    J Mol Cell Cardiol; 2014 Jul 06; 72():250-62. PubMed ID: 24732212
    [Abstract] [Full Text] [Related]

  • 28. Emodin, a naturally occurring anthraquinone, ameliorates experimental autoimmune myocarditis in rats.
    Song ZC, Wang ZS, Bai JH, Li Z, Hu J.
    Tohoku J Exp Med; 2012 Jul 06; 227(3):225-30. PubMed ID: 22791134
    [Abstract] [Full Text] [Related]

  • 29. Protective effects of carvedilol against doxorubicin-induced cardiomyopathy in rats.
    Matsui H, Morishima I, Numaguchi Y, Toki Y, Okumura K, Hayakawa T.
    Life Sci; 1999 Jul 06; 65(12):1265-74. PubMed ID: 10503942
    [Abstract] [Full Text] [Related]

  • 30. Differential effects of carvedilol and metoprolol on isoprenaline-induced changes in beta-adrenoceptor density and systolic function in rat cardiac myocytes.
    Flesch M, Ettelbrück S, Rosenkranz S, Maack C, Cremers B, Schlüter KD, Zolk O, Böhm M.
    Cardiovasc Res; 2001 Feb 01; 49(2):371-80. PubMed ID: 11164847
    [Abstract] [Full Text] [Related]

  • 31. Cardioprotective effects of carvedilol, a novel beta adrenoceptor antagonist with vasodilating properties, in anaesthetised minipigs: comparison with propranolol.
    Bril A, Slivjak M, DiMartino MJ, Feuerstein GZ, Linee P, Poyser RH, Ruffolo RR, Smith EF.
    Cardiovasc Res; 1992 May 01; 26(5):518-25. PubMed ID: 1359930
    [Abstract] [Full Text] [Related]

  • 32. Effect of carvedilol in comparison with metoprolol on myocardial collagen postinfarction.
    Wei S, Chow LT, Sanderson JE.
    J Am Coll Cardiol; 2000 Jul 01; 36(1):276-81. PubMed ID: 10898446
    [Abstract] [Full Text] [Related]

  • 33. Carvedilol protects against glomerulosclerosis in rat remnant kidney without general changes in antioxidant enzyme status. A comparative study of two beta-blocking drugs, carvedilol and propanolol.
    Van den Branden C, Gabriels M, Vamecq J, Vanden Houte K, Verbeelen D.
    Nephron; 1997 Jul 01; 77(3):319-24. PubMed ID: 9375827
    [Abstract] [Full Text] [Related]

  • 34. Differential effect of chronic treatment with two beta-blocking agents on insulin sensitivity: the carvedilol-metoprolol study.
    Jacob S, Rett K, Wicklmayr M, Agrawal B, Augustin HJ, Dietze GJ.
    J Hypertens; 1996 Apr 01; 14(4):489-94. PubMed ID: 8761899
    [Abstract] [Full Text] [Related]

  • 35. Myocardial protection with carvedilol.
    Feuerstein GZ, Hamburger SA, Smith EF, Bril A, Ruffolo RR.
    J Cardiovasc Pharmacol; 1992 Apr 01; 19 Suppl 1():S138-41. PubMed ID: 1378142
    [Abstract] [Full Text] [Related]

  • 36. [Effects of carvedilol and metoprolol on cardiac fibrosis in rats with experimental myocardial infarction].
    Sun T, Shen LH, Chen H, Li HW, Guo CY, Li ZZ, Tang CS.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Jan 01; 36(1):68-71. PubMed ID: 19099933
    [Abstract] [Full Text] [Related]

  • 37. Pharmacology of carvedilol: rationale for use in hypertension, coronary artery disease, and congestive heart failure.
    Ruffolo RR, Feuerstein GZ.
    Cardiovasc Drugs Ther; 1997 May 01; 11 Suppl 1():247-56. PubMed ID: 9211017
    [Abstract] [Full Text] [Related]

  • 38. Receptor pharmacology of carvedilol in the human heart.
    Bristow MR, Larrabee P, Minobe W, Roden R, Skerl L, Klein J, Handwerger D, Port JD, Müller-Beckmann B.
    J Cardiovasc Pharmacol; 1992 May 01; 19 Suppl 1():S68-80. PubMed ID: 1378154
    [Abstract] [Full Text] [Related]

  • 39. Norepinephrine-induced changes in rat heart function, metabolism, and weight are antagonized by carvedilol.
    Nagano T, O'Harrow S, Sponer G, Zimmer HG.
    J Cardiovasc Pharmacol; 1993 Apr 01; 21(4):530-6. PubMed ID: 7681896
    [Abstract] [Full Text] [Related]

  • 40. Carvedilol blocks beta2- more than beta1-adrenoceptors in human heart.
    Molenaar P, Christ T, Ravens U, Kaumann A.
    Cardiovasc Res; 2006 Jan 01; 69(1):128-39. PubMed ID: 16225854
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.